참고문헌
- Achen MG, Williams RA, Minekus MP, et al (2001). Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis. J Pathol, 193, 147-54. https://doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH757>3.0.CO;2-G
- Caldon CE, Lee CS, Sutherland RL, Musgrove EA (2008). Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation. Oncogene, 27, 126-38 https://doi.org/10.1038/sj.onc.1210622
- Cash J, Korchnak A, Gorman J, Tandon Y, Fraizer G (2007). VEGF transcription and mRNA stability are altered by WT1 not DDS (R384W) expression in LNCaP cells. Oncol Rep, 17, 1413-9.
- Daniela Cilloni, Francesca Messa, Arruga F (2008). Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1transcript levels in peripheral blood samples collected after chemotherapy. Haematologica, 93, 921-4. https://doi.org/10.3324/haematol.12165
- Dohi S, Ohno S, Ohno Y, et al (2010). WT1 expression correlates with angiogenesis in endometrial cancer tissue. Anticancer Res, 30, 3187-92.
- Gao L (2000). Selective elimination of leukemic CD34 (+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood, 95, 2198-203.
- Gao L (2003). Human cytotoxic T lymphocytes specific for Wilms' tumor antigen- 1 inhibit engraftment of leukemiainitiating stem cells in non-obese diabetic-severe combined immunodeficient recipients. Transplantation, 75, 1429-36. https://doi.org/10.1097/01.TP.0000061516.57346.E8
- Gessler M, Poustka A, Cavenee W, et al (1990). Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature, 343, 774-8. https://doi.org/10.1038/343774a0
- Graham K, Li W, Williams B, Fraizer G (2006). VEGF is differentially expressed in T1- and DDS-LNCaP cells. Gene Expression, 13, 1-14. https://doi.org/10.3727/000000006783991953
- Gregory McCarty OA, Loeb DM (2011. december). WT1 Protein directly regulates expression of vascular endothelial growth factor and is a mediator of tumor response to hypoxia. journal of biological chemistry, 286.
- Haber DA, Buckler AJ, T G (1990). An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell, 61, 1257-69. https://doi.org/10.1016/0092-8674(90)90690-G
- Hanson J, Gorman J, Reese J (2007). Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. Front Biosci, 12, 2279-90. https://doi.org/10.2741/2230
- Hashiba T, Izumoto S, Kagawa N, et al (2007). Expression of WT1 protein and correlation with cellular proliferation in glial tumors. Neurol Med Chir, 47, 165-70. https://doi.org/10.2176/nmc.47.165
- Hayes DF (2005). Prognostic and predictive factors revisited. Breast, 14, 493-9. https://doi.org/10.1016/j.breast.2005.08.023
- Hylander B, Repasky E, Shrikant P, et al (2006). Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer. Gynecol Oncol, 101, 12-7. https://doi.org/10.1016/j.ygyno.2005.09.052
- Inoue K, Ogawa H, Sonoda Y, et al (1997). Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood, 89, 1405-12
- Keilholz U1, Menssen HD, Gaiger A, et al (2005). Wilms' tumor gene 1 (WT1) in human neoplasia. Leukemia, 19, 1318-23. https://doi.org/10.1038/sj.leu.2403817
- Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H (1994). Vascular endothelila growth factor / vascular permeability factor is detectable in the sera of tumor bearing mice and cancer patients. Biochim Acta Biophys, 1221, 211-4. https://doi.org/10.1016/0167-4889(94)90016-7
- Korosh E, Mohammad MG, Rashid R (2012). Report of national cancer registration 2010.
- Kreidberg JA, Sariola H, Loring JM, et al (1993). WT-1 is required for early kidney development. Cell, 74, 679-91. https://doi.org/10.1016/0092-8674(93)90515-R
- Kusumoto S MI, Bessho M, Matsumoto H M S (1999). The importance of WT1 gene expression in the detection of minimal residual disease. A comparison of WT1 AML/MTG8 transcripts. Rinsho Ketsueki, 40, 511-4.
- Lee J, Gray A, Yuan J (1996). Vascular endothelial growth factorrelated protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci U S A, 93, 1988-92. https://doi.org/10.1073/pnas.93.5.1988
- Maglione D, Guerriero V, Vigeltto G, Persico M, Delli-Bovi P (1991). Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA, 88, 9267-71. https://doi.org/10.1073/pnas.88.20.9267
- Martin SK, To LB, Horvath N, Zannettino ACW (2004). Angiogenesis in multiple myeloma: implications in myeloma therapy. Cancer Rev A Pac, 02, 119-129. https://doi.org/10.1142/S0219836304000470
- McCarty G, Awad O, DM L (2011). WT1 protein directly regulates expression of vascular endothelial growth factor and is a mediator of tumor response to hypoxia. J Biol Chem, 286, 51.
- Meyer M, Clauss M, Lepple-Wienhues A, et al (1999). A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J, 18, 363-74. https://doi.org/10.1093/emboj/18.2.363
- Miyoshi Y, Ando A, Egawa C, et al (2002). High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. 8, 1167-71.
- Moazam MM, Eisermann K, Fraizer G (2010). Identifying a role for WT1 in pediatric leukemia. J Clin Oncol, 28.
- Oji Y, Miyoshi S, Maeda H, et al (2002). Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer, 100, 297-303 https://doi.org/10.1002/ijc.10476
- Oji Y, Ogawa H, Tamaki H, et al (1999). Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res, 90, 194-204. https://doi.org/10.1111/j.1349-7006.1999.tb00733.x
- Oka Y, Tsuboi A, Kawakami M, et al (2006). Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers. Curr Med Chem, 13, 2345-52. https://doi.org/10.2174/092986706777935104
- Olofsson B, Pajusola K, Kaipainen A, et al (1996). Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA, 93, 2576-81 https://doi.org/10.1073/pnas.93.6.2576
- Ozalp S, Yalcin OT, Acikalin M, et al (2003). Microvessel density (MVD) as a prognosticator in endometrial carcinoma. Eur J Gynaecol Oncol, 24, 305-8.
- Phipps, Wilma J, Donovan F (2007). Medical-surgical nursing,7 Ed, Lippincott W, Wilkins.
- Rini B (2007). Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma. Clin Cancer Res, 13, 741-6 https://doi.org/10.1158/1078-0432.CCR-06-2110
- Scharnhorst V, van der Eb AJ, Jochemsen AG (2001). WT1 proteins: functions in growth anddifferentiation. Gene, 273, 141-61 https://doi.org/10.1016/S0378-1119(01)00593-5
- Sera T, Hiasa Y, Mashiba T, et al (2008). Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis. Eur J Cancer, 44, 600-8. https://doi.org/10.1016/j.ejca.2008.01.008
- Shimizu M, Toki T, Takagi Y, Konishi I, Fujii S (2000). Immunohisto-chemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol, 19, 158-63. https://doi.org/10.1097/00004347-200004000-00010
- Sugiyama H (2001). Wilms' tumor gene WT1: its oncogenic function and clinical application. Int J Hematol, 73, 177-87. https://doi.org/10.1007/BF02981935
- Wagner N1, Panelos J, Massi D, Wagner KD (2008). The Wilms' tumor suppressor WT1 is associated with melanoma proliferation. Pflugers Arch, 455, 839-47. https://doi.org/10.1007/s00424-007-0340-1
- Xue SA (2005). Elimination of human leukemia cells in NOD/SCID mice by WT1- TCR gene-transduced human T cells. Blood, 106, 3062-7. https://doi.org/10.1182/blood-2005-01-0146
- Yamamoto S, Tsuda H KT, Maekawa K, et al (2007). Clinicopathological significance of WT1 expression in ovarian cancer: a possible accelerator of tumor progression in serous adenocarcinoma. Virchows Arch, 451, 27-35. https://doi.org/10.1007/s00428-007-0433-4
- Zamora-Avila DE1, Franco-Molina MA, Trejo-Avila LM, et al (2007). RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line. Melanoma Res, 17, 341-8. https://doi.org/10.1097/CMR.0b013e3282efd3ae
- Zand A M, Imani S, Saadati M, et al (2012). Statistical approach to discovery of factors impacting on emergence of blood cancers in Iran. Asian Pac J Cancer Prev, 13, 5965-7 https://doi.org/10.7314/APJCP.2012.13.12.5965
- Zapata-Benavides P1, Tuna M, Lopez-Berestein G, Tari AM (2002). Down-regulation of Wilms' tumor 1 protein inhibits breast cancer proliferation. Biochem Biophys Res Commun, 295, 784-90 https://doi.org/10.1016/S0006-291X(02)00751-9
피인용 문헌
- Candida non albicans with a High Amphotericin B Resistance Pattern Causing Candidemia among Cancer Patients vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10933
- Assessment of Relationship between Wilms' Tumor Gene (WT1) Expression in Peripheral Blood of Acute Leukemia Patients and Serum IL-12 and C3 Levels vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7303
- Digital gene expression profiling analysis of childhood acute lymphoblastic leukemia vol.13, pp.5, 2016, https://doi.org/10.3892/mmr.2016.5089